1. Home
  2. > Pharmaceutical Market Trends
Progressive Supranuclear Palsy Therapies Market by Type of Treatment, and Key Geographical Regions : Industry Trends and Global Forecasts, 2021-2030

Progressive Supranuclear Palsy Therapies Market by Type of Treatment, and Key Geographical Regions : Industry Trends and Global Forecasts, 2021-2030

  • August 2021
  • 106 pages
  • ID: 6189681
  • Format: PDF
  • Roots Analysis Private Ltd.


Table of Contents

The “Progressive Supranuclear Palsy (PSP) Therapies Market by Type of Treatment (Curative and Palliative / Symptomatic), and Key Geographical Regions (US, UK, Germany, France, Italy and Spain): Industry Trends and Global Forecasts, 2021-2030” report features an extensive study on molecules being evaluated in various clinical and non-clinical stage of development, for the treatment of Progressive Supranuclear Palsy.

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product’s phase of development, molecule type, mechanism of action, route of administration, regulatory milestones, and other development activities.

One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for Progressive Supranuclear Palsy, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2021-2030.

A detailed assessment of the therapeutic pipeline activity and therapeutic assessment of the products by development stage, type of molecule, mechanism of action, type of treatment, orphan drug designation and route of administration across the complete product development cycle, including all clinical and non-clinical stages.
An analysis of the overall developer landscape of the market, highlighting the contributions of industry and non-industry players, along with information on their year of establishment, company size, ownership and geographical location of headquarters.
A case study on the dormant, terminated and other programs; it features a list of therapies that have been discontinued or have no recent updates on their development phase transition. In addition, it presents a list of generic and non-generic drugs that can be explored as treatment options for Progressive Supranuclear Palsy.
A detailed analysis of completed, ongoing and planned clinical studies, based on the various relevant parameters, such as trial registration year, trial phase, number of patients enrolled, study design, trial recruitment status, and trial focus, highlighting leading sponsors, type of organization, type of treatment, purpose of study and regional distribution of trials.
A detailed analysis identifying the key opinion leaders (KOLs), featuring a 2X2 analysis to assess the relative experience of certain KOLs who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field.
Information on the grants awarded to research institutes for the projects related to progressive Supranuclear Palsy, during the period 2010 and 2021, based on several important parameters, such year of grant award, amount awarded, administering institute center, support period, type of grant application, purpose of grant award, activity code, focus area, study section involved, and type of recipient organizations. In addition, it highlights popular funding institute centers, prominent program officers, and popular recipient organizations.
A detailed review of over 2,000 peer-reviewed, scientific articles related to research on progressive Supranuclear Palsy, which have been published between 2009 and 2021, including analysis based on parameters, such as year of publication, emerging focus areas, most popular authors, and key journals (in terms of number of articles published in this domain and impact factor of the journal).
An analysis of the partnerships that have been established in the domain, over the last seven years, covering research and development agreements, product / technology licensing agreements, product development agreements, mergers / acquisitions, clinical trial agreements, and other relevant deals.
Detailed profiles of the players that are engaged in the development of drug products / therapies for Progressive Supranuclear Palsy, featuring overview of the company, its financial information (if available), a description of its product portfolio, recent collaborations and an informed future outlook.
An insightful market forecast analysis, highlighting the likely launch year of several late- stage therapies, their global and regional sales projections and the likely growth of the overall market till the year 2030. In order to provide a detailed future outlook, our projections have been segmented across different types of treatments (curative, palliative / symptomatic) and key geographical locations (US, UK, Germany, France, Italy and Spain).
A collection of interview transcripts of the discussions held with key stakeholders in the industry. We have presented details of interviews held with Daniel Brennan (Business and Operations Advisor, NeuroTau), and Fabrizio Stocchi (Professor, IRCCS San Raffaele).

In the coming years, the market is anticipated to grow at a steady pace owing to the rising awareness of the disease and increasing interest of stakeholders to invest in this field.
More novel therapy solutions are being developed by various industry as well as non-industry stakeholders, which are actively focused on addressing the challenges related to treatment of Progressive Supranuclear Palsy.
The significant impact on market size can also be attributed to the contributions of several big pharma players being actively involved in evaluation of various therapy candidates in this field.
With various potential therapies under clinical investigation, a marked rise is anticipated in the number of new entrants in the market, in the coming years.

What are the prevalent R&D trends related to Progressive Supranuclear Palsy?
What are the key challenges faced by stakeholders engaged in this domain?
What are the principal therapies developed by the companies in this domain?
Who are the leading industry and non-industry players in this market?
What are the contributions of big pharma players in this field?
Which are the most active clinical trial centers?
Who are the key investors in this domain?
Who are the key opinion leaders / experts in this field?
What kind of partnership models are commonly adopted by industry stakeholders?
What are the factors that are likely to influence the evolution of this upcoming market?
How is the current and future market opportunity likely to be distributed across key market segments?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Regulatory Affairs Outsourcing Market Research Report by Service, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • October 2022
  • 255 pages

Regulatory Affairs Outsourcing Market Research Report by Service, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 The Global Regulatory Affairs Outsourcing Market size was estimated ...

  • World
  • Clinical Trial
  • Marketing Research
  • Industry analysis


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on